Clinical trials in Athens, GA

18 recruiting studies have a site in or near Athens, GA, Georgia.

Top conditions here

All conditions

Showing 18 of 18 studies

RecruitingPhase 3NCT06841354

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

Sponsor: Merck Sharp & Dohme LLC

Athens, GA · +38 more sites

RecruitingPhase 1NCT07310420

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

Sponsor: TerSera Therapeutics LLC

Athens, GA · Savannah, GA · +24 more sites

RecruitingPhase 2NCT06031688

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Sponsor: SWOG Cancer Research Network

Athens, GA · Gainesville, GA · +276 more sites

RecruitingPhase 3NCT07222800

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Sponsor: Pfizer

Athens, GA · +253 more sites

RecruitingPhase 3NCT06119581

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Sponsor: Eli Lilly and Company

Athens, GA · Atlanta, GA · +84 more sites

RecruitingPhase 3NCT07361510

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

Sponsor: Bristol-Myers Squibb

Athens, GA · Augusta, GA · Marietta, GA · +38 more sites

RecruitingPhase 2 / Phase 3NCT06780670

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

Sponsor: Novartis Pharmaceuticals

Athens, GA · Atlanta, GA · +33 more sites

RecruitingPhase 3NCT06492616

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Sponsor: Stemline Therapeutics, Inc.

Athens, GA · Atlanta, GA · +173 more sites

RecruitingNot applicableNCT06382298

Cottonseed Oil Versus Matched PUFA Effects

Sponsor: University of Georgia

Athens, GA

RecruitingNot applicableNCT07246408

Intermittent Cottonseed Oil Consumption

Sponsor: University of Georgia

Athens, GA

RecruitingPhase 3NCT05879926

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Sponsor: NRG Oncology

Albany, GA · Athens, GA · Atlanta, GA · +1223 more sites

RecruitingPhase 3NCT05812807

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Sponsor: Alliance for Clinical Trials in Oncology

Albany, GA · Athens, GA · Atlanta, GA · +825 more sites

RecruitingPhase 2NCT05642572

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Sponsor: SWOG Cancer Research Network

Athens, GA · Atlanta, GA · +451 more sites

RecruitingPhase 4NCT04580134

CLOZAPINE Response in Biotype-1

Sponsor: University of Texas Southwestern Medical Center

Athens, GA · +4 more sites

RecruitingPhase 2NCT05168566

Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer

Sponsor: Teligene US

Athens, GA · +5 more sites

RecruitingPhase not listedNCT06740383

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

Sponsor: Beth Israel Deaconess Medical Center

Athens, GA · +5 more sites

RecruitingNot applicableNCT04414215

Cognitive Training for Emotion Regulation in Psychotic Disorders

Sponsor: University of Georgia

Athens, GA

Not yet recruitingNot applicableNCT07696403

Cardiometabolic Effects of the Recommended Daily Pecan Intake Dose

Sponsor: University of Georgia

Athens, GA

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.